Keyword: Neurocrine Biosciences
Due to the COVID-19 pandemic, Neurocrine won't launch its new medicine Ongentys right away.
Which rollouts might suffer most? Those that treat chronic diseases, require doctors to administer them or face current competition, analysts say.
3. Neurocrine Biosciences
While biopharma CEOs often catch the limelight for their multimillion-dollar paychecks, it is every diligent worker that forms a company—and some of them also get paid handsomely. Here, we rank the top 10 most generous biopharma companies by median employee pay in 2018.
Pharma's big on disease awareness, but Allergan is going really big with its latest push: It’s aiming for a whole month dedicated to uterine fibroids.